GlassScriptPhysician profile
Gregory C Frank
NPI 1093159014
$2,009.14
in general payments reported to CMS, 2019-2025
18 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $239 · 2022: $109 · 2023: $356 · 2024: $986 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $657.81 | 2022-2025 | Sapien 3 Ultra Resilia |
| Atricure, INC. | $219.69 | 2021-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Medtronic, INC. | $157.17 | 2021-2023 | Endurant Iis |
| Boston Scientific Corporation | $140.11 | 2024 | Watchman Flx |
| Abbott Laboratories | $138.99 | 2024-2025 | Esprit, Epic, Navitor |
| Abiomed | $115.10 | 2024-2025 | Impella |
| Baxter Healthcare | $107.97 | 2023-2025 | Perclot, Preveleak, Tisseel |
| Inspire Medical Systems, INC. | $97.67 | 2024 | Inspire |
| Haemonetics Corporation | $78.49 | 2024 | Teg6s Hemostasis System |
| Alexion Pharmaceuticals, INC. | $72.91 | 2021 | |
| Davol INC. | $42.94 | 2024 | Arista Ah Flexitip |
| La Jolla Pharmaceutical Company | $30.85 | 2024 | Giapreza |
| Kyowa Kirin, INC. | $29.55 | 2024 | Crysvita |
| Getinge USA Sales, LLC | $29.10 | 2021 | |
| Zimmer Biomet Holdings, INC. | $27.33 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $26.27 | 2022 | |
| Lemaitre Vascular, INC. | $22.62 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $14.57 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.